Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: uniQure N.V., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Corbus Pharmaceuticals Holdings Inc. May 13, 202695.8%
-
Corbus Pharmaceuticals Holdings Inc. May 15, 202598.3%
-
Corbus Pharmaceuticals Holdings Inc. May 16, 202493.7%
-
Corbus Pharmaceuticals Holdings Inc. May 18, 202382.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | uniQure N.V. | Open-market sale | −1,993 | $27.06 | $53,931 |
| Jun 10, 2026 | uniQure N.V. | Grant or award | +7,550 | — | — |
| May 19, 2026 | Corbus Pharmaceuticals Holdings Inc. | Grant or award | +3,800 | — | — |
| Jun 20, 2025 | uniQure N.V. | Open-market sale | −2,112 | $14.45 | $30,518 |
| Jun 11, 2025 | uniQure N.V. | Grant or award | +7,970 | — | — |
| May 30, 2025 | Corbus Pharmaceuticals Holdings Inc. | Grant or award | +4,800 | — | — |
| Jun 19, 2024 | uniQure N.V. | Grant or award | +8,080 | — | — |
| Jun 13, 2024 | uniQure N.V. | Open-market sale | −2,221 | $5.14 | $11,416 |
| May 30, 2024 | Corbus Pharmaceuticals Holdings Inc. | Grant or award | +2,783 | — | — |
| Apr 26, 2024 | Akari Therapeutics plc | Grant or award | +479,569,892 | — | — |
| Jun 16, 2023 | uniQure N.V. | Open-market sale | −2,301 | $18.76 | $43,167 |
| Jun 13, 2023 | uniQure N.V. | Grant or award | +8,700 | — | — |
| Feb 27, 2023 | uniQure N.V. | Open-market sale | −384 | $20.02 | $7,688 |
Questions about Rachelle Suzanne Jacques
What boards is Rachelle Suzanne Jacques on?
Rachelle Suzanne Jacques sits on the boards of Akari Therapeutics plc, Corbus Pharmaceuticals Holdings Inc. and uniQure N.V.
What company is Rachelle Suzanne Jacques the CEO of?
Rachelle Suzanne Jacques has been Chief Executive Officer of Akari Therapeutics plc since January 2024.
How long has Rachelle Suzanne Jacques served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.